Front Endocrinol (Lausanne)
May 2023
Objective: To analyze and determine the safety and efficacy of growth hormone (GH) treatment in Down syndrome (DS) pediatric patients and to weigh ethical aspects involved.
Design: Systematic review and mini meta-analysis of the literature.
Methods: A search was performed in PubMed, Embase, Scopus, and PsycINFO through August 2022.
Objective: To analyze and determine the quality of functioning in different components of GHRH-GH-IGF1 axis in children with Down syndrome (DS).
Design: Systematic review and mini meta-analysis of the literature.
Methods: A search was performed in PubMed, Embase, Scopus, and PsycINFO through August 2022.